
Please try another search
Harmony Biosciences Management, Inc. operates as a clinical stage specialty pharmaceutical company. The company focuses on developing pharmaceutically produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. It is developing Zygel, a pharmaceutically produced cannabidiol formulated as a permeation-enhanced gel for transdermal delivery. Harmony Biosciences Management, Inc. was formerly known as Zynerba Pharmaceuticals, Inc. and changed its name Harmony Biosciences Management, Inc. in July 2024. Harmony Biosciences Management, Inc. was incorporated in 2007 and is headquartered in Devon, Pennsylvania. As of October 10, 2023, Harmony Biosciences Management, Inc. operates as a subsidiary of Harmony Biosciences Holdings, Inc.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review